1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Optic Neuropathy Global Clinical Trials Review, H1, 2015

Optic Neuropathy Global Clinical Trials Review, H1, 2015

  • January 2015
  • -
  • Global Data
  • -
  • 66 pages

Optic Neuropathy Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Optic Neuropathy Global Clinical Trials Review, H1, 2015" provides data on the Optic Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Optic Neuropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Optic Neuropathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Optic Neuropathy Global Clinical Trials Review, H1, 2015
Introduction 6
Optic Neuropathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Optic Neuropathy to Ophthalmology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Optic Neuropathy to Ophthalmology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Optic Neuropathy Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Sigma-Tau S.p.A. 28
Clinical Trial Overview of Sigma-Tau S.p.A. 28
SBI Biotech Co., Ltd. 29
Clinical Trial Overview of SBI Biotech Co., Ltd. 29
Regenera Pharma Ltd. 30
Clinical Trial Overview of Regenera Pharma Ltd. 30
Highmark Inc. 31
Clinical Trial Overview of Highmark Inc. 31
Eli Lilly and Company 32
Clinical Trial Overview of Eli Lilly and Company 32
Bayer AG 33
Clinical Trial Overview of Bayer AG 33
Allergan, Inc. 34
Clinical Trial Overview of Allergan, Inc. 34
Clinical Trial Overview of Top Institutes / Government 35
Tehran University of Medical Sciences 35
Clinical Trial Overview of Tehran University of Medical Sciences 35
Shahid Beheshti University of Medical Sciences 36
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 36
Hong Kong Eye Hospital 37
Clinical Trial Overview of Hong Kong Eye Hospital 37
Second Military Medical University 38
Clinical Trial Overview of Second Military Medical University 38
Jikei University School of Medicine 39
Clinical Trial Overview of Jikei University School of Medicine 39
Isfahan University of Medical Sciences 40
Clinical Trial Overview of Isfahan University of Medical Sciences 40
Mount Sinai Hospital 41
Clinical Trial Overview of Mount Sinai Hospital 41
University of Colorado 42
Clinical Trial Overview of University of Colorado 42
University Hospital Tubingen 43
Clinical Trial Overview of University Hospital Tubingen 43
National Eye Institute 44
Clinical Trial Overview of National Eye Institute 44
Five Key Clinical Profiles 45
Appendix 64
Abbreviations 64
Definitions 64
Research Methodology 65
Secondary Research 65
About GlobalData 66
Contact Us 66
Disclaimer 66
Source 66

List of Tables

Optic Neuropathy Therapeutics, Global, Clinical Trials by Region, 2015* 7
Optic Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Optic Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Optic Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Optic Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Optic Neuropathy Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Optic Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Optic Neuropathy to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14
Optic Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Optic Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Optic Neuropathy to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17
Optic Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Optic Neuropathy Therapeutics, Global, Clinical Trials by Phase, 2015* 19
Optic Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20
Optic Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Optic Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Optic Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Optic Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24
Optic Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Optic Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Optic Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sigma-Tau S.p.A., 2015* 28
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by SBI Biotech Co., Ltd., 2015* 29
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Regenera Pharma Ltd., 2015* 30
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Highmark Inc., 2015* 31
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 32
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 33
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2015* 34
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 35
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 36
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hong Kong Eye Hospital, 2015* 37
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Second Military Medical University, 2015* 38
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Jikei University School of Medicine, 2015* 39
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 40
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai Hospital, 2015* 41
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2015* 42
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Tubingen, 2015* 43
Optic Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 44

List of Figures

Optic Neuropathy Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Optic Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Optic Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Optic Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Optic Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Optic Neuropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Optic Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Optic Neuropathy to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14
Optic Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Optic Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Optic Neuropathy to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17
Optic Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Optic Neuropathy Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19
Optic Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20
Optic Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Optic Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Optic Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Optic Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24
Optic Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Optic Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26
Optic Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27
GlobalData Methodology 65

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.